Join
Live feed
·
INSIDERFilingvia Quantisnow
Amphastar Pharmaceuticals Inc. logo

CEO & CHIEF SCIENTIFIC OFFICER Zhang Jack Y. was granted 165,222 shares, increasing direct ownership by 5% to 2,609,382 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
AMPH· Amphastar Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AMPH (Amphastar Pharmaceuticals Inc.) and more on Quantisnow.